Cargando…

Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study

BACKGROUND: Health-related quality of life (QoL) has prognostic value in many cancers. A recent study found that the performance of prognostic systems for metastatic colorectal cancer (mCRC) were improvable. We evaluated the independent prognostic value of QoL for overall survival (OS) and its abili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diouf, Momar, Chibaudel, Benoist, Filleron, Thomas, Tournigand, Christophe, Hug de Larauze, Marine, Garcia-Larnicol, Marie-Line, Dumont, Sarah, Louvet, Christophe, Perez-Staub, Nathalie, Hadengue, Alexandra, de Gramont, Aimery, Bonnetain, Franck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029890/ https://www.ncbi.nlm.nih.gov/pubmed/24886671 http://dx.doi.org/10.1186/1477-7525-12-69

Ejemplares similares

STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer
por: Chibaudel, Benoist, et al.
Publicado: (2015)

Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial
por: Hamidou, Zeinab, et al.
Publicado: (2016)

PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM‐398) or irinotecan with leucovorin/5‐fluorouracil as second‐line therapy in metastatic colorectal cancer
por: Chibaudel, Benoist, et al.
Publicado: (2016)

A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR trial
por: Bachet, Jean-Baptiste, et al.
Publicado: (2015)

RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study
por: Cohen, Romain, et al.
Publicado: (2020)

Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial
por: Charton, Emilie, et al.
Publicado: (2019)

Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study
por: Chibaudel, Benoist, et al.
Publicado: (2015)

Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study
por: André, Thierry, et al.
Publicado: (2023)

MAINTENANCE HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST CANCER
por: Dufresne, Armelle, et al.
Publicado: (2008)

FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer
por: Carola, Candice, et al.
Publicado: (2018)

Validation of the Dutch version of the Swallowing Quality-of-Life Questionnaire (DSWAL-QoL) and the adjusted DSWAL-QoL (aDSWAL-QoL) using item analysis with the Rasch model: a pilot study
por: Simpelaere, Ingeborg S., et al.
Publicado: (2017)

Obesity Is a Marker of Reduction in QoL and Disability
por: Sirtori, Anna, et al.
Publicado: (2012)

The Importance of Connection to Others in QoL in MSA and PSP
por: Wiblin, Louise, et al.
Publicado: (2017)

Quality of life in childhood advanced cancer: from conceptualization to assessment with the Advance QoL tool
por: Avoine-Blondin, Josianne, et al.
Publicado: (2022)

Quality of life (QoL) for people with primary sclerosing cholangitis (PSC): a pragmatic strategy for identifying relevant QoL issues for rare disease
por: Marcus, Elena, et al.
Publicado: (2022)

Health related QoL in celiac disease patients in Slovenia
por: Turk, Eva, et al.
Publicado: (2020)

Determining the Minimal Important Difference for the Wound-QoL Questionnaire
por: Topp, Janine, et al.
Publicado: (2021)

RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study
por: Lucidarme, Olivier, et al.
Publicado: (2019)

Tinnitus in elderly population: clinic correlations and impact upon QoL
por: Negrila-Mezei, A., et al.
Publicado: (2011)

Deriving reference values and utilities for the QoL-AGHDA in adult GHD
por: Busschbach, J. J. V., et al.
Publicado: (2010)

A new questionnaire for measuring quality of life - the Stark QoL
por: Hardt, Jochen
Publicado: (2015)

Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
por: Cazzorla, Chiara, et al.
Publicado: (2014)

A Narrative Approach to Describe QoL in Children With Chronic ITP
por: Giordano, Paola, et al.
Publicado: (2019)

A translation and preliminary validation of the Dutch Wound-QoL questionnaire
por: Amesz, Stella F., et al.
Publicado: (2020)

Improving Social Support to Increase QoL in Lung Cancer Patients
por: Hofman, Adriana, et al.
Publicado: (2021)

QoL Following Dacryocystorhinostomy: Linguistic Adaptation of Italian Version of GBI
por: Cantone, Elena, et al.
Publicado: (2023)

Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study
por: Evrard, Diane, et al.
Publicado: (2022)

Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes—An ESDO Report
por: Van Cutsem, Eric, et al.
Publicado: (2017)

Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study)
por: Kim, Stefano, et al.
Publicado: (2017)

Corrigendum: A Narrative Approach to Describe QoL in Children With Chronic ITP
por: Giordano, Paola, et al.
Publicado: (2019)

The Effect of Alterations in Consciousness on Quality of Life (QoL) in Epilepsy: Searching for Evidence
por: Charidimou, Andreas, et al.
Publicado: (2011)

Angioedema quality of life questionnaire (AE-QoL) - interpretability and sensitivity to change
por: Kulthanan, Kanokvalai, et al.
Publicado: (2019)

Neurology, Neurorehabilitation and Aspects Related to Neuro-Quality of Life (Neuro-QoL)
por: Purcarea, Victor Lorin
Publicado: (2019)

MON-268 Factors Associated With QoL Impairment In Patients With Acromegaly In The Elderly
por: Yamamoto, Naoki, et al.
Publicado: (2020)

Adaptability and clinical applicability of UFS-QoL in Chinese women with uterine fibroid
por: Xu, Wei, et al.
Publicado: (2022)

Stress Estimation Using Biometric and Activity Indicators to Improve QoL of the Elderly †
por: Matsumoto, Kanta, et al.
Publicado: (2023)

Anorectal Malformations: Ideal Surgery Timing to Reduce Incontinence and Optimize QoL
por: Pelizzo, Gloria, et al.
Publicado: (2023)

Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)
por: Tougeron, David, et al.
Publicado: (2021)

Rationale and design of the Adapted Physical Activity in advanced Pancreatic Cancer patients (APACaP) GERCOR (Groupe Coopérateur Multidisciplinaire en Oncologie) trial: study protocol for a randomized controlled trial
por: Neuzillet, Cindy, et al.
Publicado: (2015)

Analysis of longitudinal oncology quality of life (QoL) data - are we getting it right?
por: Cocks, Kim, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9gdm9sgaea7p4q88od6ou00rh4